Related Experiment Video
Updated: Jul 14, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
The 14-3-3sigma, upregulated by p53 in response to DNA damage, can have a positive-feedback impact driving p53 activities and is a human cancer epithelial marker downregulated in various tumors. However, the precise roles of 14-3-3sigma during tumorigenesis are not well characterized. Here, we show that 14-3-3sigma is a critical regulator of murine double minute oncogene (MDM2). 14-3-3sigma interacts with MDM2 at the RING domain. The C-terminal region of 14-3-3sigma binds to MDM2 very efficiently. Importantly, 14-3-3sigma overexpression leads to destabilization of MDM2 through enhancing MDM2 self-ubiquitination and accelerating turnover rate. Conversely, loss of 14-3-3sigma results in a significant increase in MDM2 protein. Moreover, live-cell images indicated that 14-3-3sigma can affect the location of MDM2 from the nucleus to the cytoplasm, and that MDM2-mediated cytoplasmic localization of p53 can be reversed by the presence of 14-3-3sigma. Significantly, we further showed that 14-3-3sigma causes MDM2 downregulation, thereby stabilizing p53 and inhibiting tumor growth in animal tumors. Also, 14-3-3sigma blocks MDM2-mediated retinoblastoma degradation and p53 NEDDylation. Our results provide evidence that 14-3-3sigma is a pivotal MDM2 regulator involved in blocking a variety of activities of MDM2.
Insights
The protein 14-3-3sigma regulates MDM2, a key factor in cancer. By destabilizing MDM2, 14-3-3sigma stabilizes p53, inhibiting tumor growth and blocking MDM2
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- 14-3-3sigma is a p53-upregulated protein involved in DNA damage response.
- Its role in tumorigenesis is not fully understood.
- 14-3-3sigma is an epithelial marker often downregulated in human cancers.
Purpose of the Study:
- To investigate the precise roles of 14-3-3sigma in tumorigenesis.
- To elucidate the regulatory relationship between 14-3-3sigma and MDM2.
- To determine how 14-3-3sigma influences p53 stability and tumor growth.
Main Methods:
- Protein interaction studies (e.g., RING domain binding).
- Overexpression and knockout studies to assess MDM2 protein levels and turnover.
- Live-cell imaging to track protein localization (MDM2, p53).
- In vivo tumor growth inhibition assays.
- Analysis of MDM2-mediated post-translational modifications (ubiquitination, NEDDylation).
Main Results:
- 14-3-3sigma directly interacts with MDM2, particularly at the RING domain.
- Overexpression of 14-3-3sigma destabilizes MDM2 by enhancing its self-ubiquitination and accelerating turnover.
- Loss of 14-3-3sigma leads to increased MDM2 protein levels.
- 14-3-3sigma influences MDM2 localization from the nucleus to the cytoplasm, reversing MDM2-mediated p53 cytoplasmic localization.
- 14-3-3sigma downregulates MDM2, stabilizing p53 and inhibiting tumor growth in vivo.
- 14-3-3sigma blocks MDM2-mediated retinoblastoma degradation and p53 NEDDylation.
Conclusions:
- 14-3-3sigma is a critical regulator of MDM2.
- 14-3-3sigma inhibits tumorigenesis by destabilizing MDM2, stabilizing p53, and blocking MDM2's oncogenic activities.
- These findings highlight 14-3-3sigma as a potential therapeutic target in cancer.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Master Transcription Regulators
Positive Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules

